Imago BioSciences, Inc. Common stock
IMGO
IMGO was delisted on the 10th of January, 2023.
62 hedge funds and large institutions have $417M invested in Imago BioSciences, Inc. Common stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
59% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 17
5% more funds holding
Funds holding: 59 → 62 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
28% less capital invested
Capital invested by funds: $576M → $417M (-$159M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$12.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.37M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$3.28M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$3.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kingdon Capital Management
New York
|
-$5.01M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$2.54M |
| 4 |
Blackstone Inc
New York
|
-$979K |
| 5 |
AP
AlpInvest Partners
Amsterdam,
Netherlands
|
-$957K |
IMGO Hedge Fund Activity: Q2 2022 in Review
62 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Imago BioSciences, Inc. Common stock (IMGO) for Q2 2022, worth a combined $417M — down 28% from $576M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new IMGO positions and 5 closed out — a net gain of 4 holders — while 27 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $12.3M. The largest seller was Kingdon Capital Management, exiting entirely with an estimated $5.01M sold.
- 62 institutional investors held Imago BioSciences, Inc. Common stock (IMGO) as of Q2 2022, up from 59 in Q1 2022.
- Funds reported $417M of Imago BioSciences, Inc. Common stock stock for Q2 2022, down 28% quarter-over-quarter.
- 9 funds opened new Imago BioSciences, Inc. Common stock positions in Q2 2022 and 5 closed out, a net change of +4 holders.
- The largest Imago BioSciences, Inc. Common stock buyer in Q2 2022 was BlackRock, an estimated $12.3M added.
- The largest Imago BioSciences, Inc. Common stock seller in Q2 2022 was Kingdon Capital Management, an estimated $5.01M sold.
Based on aggregated 13F filings for Q2 2022.